Clinical trial autologous transplant cord blood. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy28

Fetal Blood Spinal Cord Transplants Umbilical Cord Hematopoietic Stem Cells Cells, Cultured T-Lymphocytes Leukocytes, Mononuclear Bone Marrow Cells Stem Cells Lymphocytes Spermatic Cord Dendritic Cells T-Lymphocytes, Cytotoxic Blood Cells Killer Cells, Natural CD4-Positive T-Lymphocytes Antilymphocyte Serum Bone Marrow B-Lymphocytes Mesenchymal Stromal Cells Monocytes CD8-Positive T-Lymphocytes Kidney T-Lymphocytes, Regulatory Allografts Placenta Clone Cells

Organisms5

Mice, SCID Mice, Inbred NOD Transplantation Chimera Cytomegalovirus Mice, Inbred C57BL

Diseases35

Hodgkin Disease Recurrence Multiple Myeloma Spinal Cord Injuries Graft vs Host Disease Postoperative Complications Hematologic Neoplasms Neoplasms Cytomegalovirus Infections Spinal Cord Diseases Acute Disease Spinal Cord Compression Leukemia Lymphoma, Non-Hodgkin Disease Models, Animal Kidney Failure, Chronic Chronic Disease Spinal Cord Ischemia Spinal Cord Neoplasms Cadaver Leukemia, Myeloid, Acute Disease Progression Hematologic Diseases Liver Failure Breast Neoplasms Melanoma Precursor Cell Lymphoblastic Leukemia-Lymphoma Opportunistic Infections HIV Infections Infection Anemia, Aplastic Lymphoma Paraplegia Kidney Diseases Bronchiolitis Obliterans

Chemicals and Drugs40

Antigens, CD34 Immunosuppressive Agents Cyclosporine Tacrolimus HLA Antigens Antigens, CD Antineoplastic Agents Cyclophosphamide Antibodies, Monoclonal Melphalan Placebos Biological Markers Mycophenolic Acid Carmustine Cancer Vaccines Myeloablative Agonists Interleukin-2 Cytokines Etoposide Granulocyte Colony-Stimulating Factor Antigens, Neoplasm Antilymphocyte Serum Interferon-gamma Busulfan Antigens, CD38 Recombinant Proteins Antigens, CD45 Prednisone Immunoglobulin G Antiviral Agents ADP-ribosyl Cyclase Cytarabine Granulocyte-Macrophage Colony-Stimulating Factor Isoantibodies Drug Combinations Stem Cell Factor Thiotepa Vincristine Cord Factors Sirolimus

Analytical, Diagnostic and Therapeutic Techniques and Equipment106

Transplantation, Autologous Hematopoietic Stem Cell Transplantation Transplantation, Homologous Bone Marrow Transplantation Clinical Trials as Topic Transplantation Conditioning Hematopoietic Stem Cell Mobilization Treatment Outcome Survival Analysis Retrospective Studies Kidney Transplantation Blood Transfusion, Autologous Clinical Trials, Phase III as Topic Clinical Trials, Phase II as Topic Follow-Up Studies Heart Transplantation Clinical Trials, Phase I as Topic Double-Blind Method Research Design Prospective Studies Stem Cell Transplantation Transplantation Combined Modality Therapy Histocompatibility Testing Controlled Clinical Trials as Topic Lung Transplantation Patient Selection Antineoplastic Combined Chemotherapy Protocols Randomized Controlled Trials as Topic Survival Rate Immunosuppression Risk Factors Flow Cytometry Cell Separation Fetal Tissue Transplantation Cord Blood Stem Cell Transplantation Disease-Free Survival Immunophenotyping Pilot Projects Prognosis Multicenter Studies as Topic Lymphocyte Activation Drug Therapy, Combination Colony-Forming Units Assay Peripheral Blood Stem Cell Transplantation Cell Culture Techniques Placebos Cell Transplantation Clinical Protocols Drug Administration Schedule Whole-Body Irradiation Feasibility Studies Single-Blind Method Blood Preservation Clinical Trials, Phase IV as Topic Lymphocyte Culture Test, Mixed Severity of Illness Index Remission Induction Cohort Studies Immunotherapy Disease Models, Animal Blood Cell Count Risk Assessment Incidence Bone Marrow Purging Coculture Techniques Early Termination of Clinical Trials Salvage Therapy Multivariate Analysis Transplantation, Heterologous Kaplan-Meier Estimate Blood Transfusion Immunotherapy, Adoptive Reproducibility of Results Cryopreservation Analysis of Variance Administration, Oral Genetic Therapy Statistics, Nonparametric Biopsy Sample Size Predictive Value of Tests Polymerase Chain Reaction Questionnaires Tissue Transplantation Treatment Failure Brain Tissue Transplantation Leukocyte Count Proportional Hazards Models Registries Immunohistochemistry Heart-Lung Transplantation Transplantation, Heterotopic Drug Evaluation Pain Measurement Fatal Outcome Cell- and Tissue-Based Therapy Sensitivity and Specificity Infusions, Intravenous Mesenchymal Stem Cell Transplantation Random Allocation Transduction, Genetic Cell Count Transplantation, Isogeneic Platelet Count Endpoint Determination

Psychiatry and Psychology1

Patient Compliance

Phenomena and Processes28

Graft Survival Time Factors Graft Rejection Pregnancy Maternal-Fetal Exchange Cell Differentiation Lymphocyte Activation Histocompatibility Transplantation Immunology Dose-Response Relationship, Drug Cytotoxicity, Immunologic Hematopoiesis Immunocompromised Host Blood Cell Count Recovery of Function Cell Proliferation Cell Lineage Leukocyte Count Genetic Vectors Cell Division Gestational Age Sensitivity and Specificity Transduction, Genetic Phenotype Cell Count Cell Survival Transplantation Tolerance Platelet Count

Disciplines and Occupations4

Research Design Outcome Assessment (Health Care)Immunohistochemistry Evidence-Based Medicine

Anthropology, Education, Sociology and Social Phenomena2

Quality of Life Informed Consent

Humanities1

Quality of Life

Information Science5

Survival Rate Incidence Questionnaires Registries Fatal Outcome

Named Groups5

Infant, Newborn Tissue Donors Living Donors Research Subjects Blood Donors

Health Care52

Clinical Trials as Topic Treatment Outcome Survival Analysis Retrospective Studies Blood Banks Clinical Trials, Phase III as Topic Clinical Trials, Phase II as Topic Follow-Up Studies Clinical Trials, Phase I as Topic Double-Blind Method Prospective Studies Controlled Clinical Trials as Topic Patient Selection Randomized Controlled Trials as Topic Survival Rate Risk Factors Tissue and Organ Procurement Disease-Free Survival Pilot Projects Multicenter Studies as Topic Waiting Lists Clinical Protocols Feasibility Studies Clinical Trials Data Monitoring Committees Single-Blind Method Clinical Trials, Phase IV as Topic Severity of Illness Index Cohort Studies Directed Tissue Donation Risk Assessment Incidence Early Termination of Clinical Trials Multivariate Analysis Age Factors Kaplan-Meier Estimate Outcome Assessment (Health Care)Reproducibility of Results Analysis of Variance Cost-Benefit Analysis Statistics, Nonparametric Maternal Exposure Sample Size Predictive Value of Tests Questionnaires Treatment Failure Proportional Hazards Models Registries Fatal Outcome Sensitivity and Specificity Random Allocation Patient Compliance Informed Consent

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Transplantation, Autologous Hematopoietic Stem Cell Transplantation Transplantation, Homologous Bone Marrow Transplantation Fetal Blood Clinical Trials as Topic Transplantation Conditioning Hematopoietic Stem Cell Mobilization Treatment Outcome Hodgkin Disease Recurrence Multiple Myeloma Spinal Cord Survival Analysis Retrospective Studies Spinal Cord Injuries Kidney Transplantation Blood Transfusion, Autologous Transplants Graft Survival Umbilical Cord Time Factors Blood Banks Graft Rejection Infant, Newborn Antigens, CD34 Immunosuppressive Agents Clinical Trials, Phase III as Topic Tissue Donors Clinical Trials, Phase II as Topic Hematopoietic Stem Cells Follow-Up Studies Heart Transplantation Clinical Trials, Phase I as Topic Pregnancy Double-Blind Method Research Design Prospective Studies Stem Cell Transplantation Transplantation Combined Modality Therapy Histocompatibility Testing Controlled Clinical Trials as Topic Graft vs Host Disease Lung Transplantation Patient Selection Cells, Cultured Postoperative Complications T-Lymphocytes Hematologic Neoplasms Antineoplastic Combined Chemotherapy Protocols Cyclosporine Randomized Controlled Trials as Topic Survival Rate Neoplasms Immunosuppression Risk Factors Flow Cytometry Tacrolimus Cell Separation Fetal Tissue Transplantation Tissue and Organ Procurement Maternal-Fetal Exchange Cord Blood Stem Cell Transplantation Disease-Free Survival Cell Differentiation Immunophenotyping HLA Antigens Pilot Projects Antigens, CD Cytomegalovirus Infections Antineoplastic Agents Mice, SCID Living Donors Prognosis Multicenter Studies as Topic Lymphocyte Activation Spinal Cord Diseases Cyclophosphamide Leukocytes, Mononuclear Drug Therapy, Combination Acute Disease Antibodies, Monoclonal Colony-Forming Units Assay Melphalan Peripheral Blood Stem Cell Transplantation Cell Culture Techniques Placebos Waiting Lists Bone Marrow Cells Cell Transplantation Clinical Protocols Spinal Cord Compression Drug Administration Schedule Biological Markers Whole-Body Irradiation Histocompatibility Feasibility Studies Transplantation Immunology Leukemia

No FAQ available that match "clinical trial autologous transplant cord blood"